Breaking News: WSAVA's Bold Move Shakes the Foundations of Animal Care! You Won't Believe What They're Saying About Cosmetic Alterations
In a groundbreaking move, the World Small Animal Veterinary Association (WSAVA) has released a powerful Position Statement condemning the physical alteration of animals for cosmetic or behavioral control purposes. The statement not only addresses the ethical concerns surrounding such practices but also underscores the importance of prioritizing animal welfare over human preferences or tradition.
Meet the Hero Vet Turning the Tide in America's Overwhelmed Animal Shelters
In an inspiring move that spells hope for countless animals, Laura Parkhurst has joined the Virginia-Maryland College of Veterinary Medicine as a clinical instructor, right in the thick of a national crisis engulfing the nation's animal shelters. As the pendulum swings back from the pandemic pet adoption boom, shelters find themselves grappling with an influx of pets, many of which struggle with behavioral issues due to under-socialization, pushing these facilities to their limits.
Why Most Dogs with Bladder Cancer Are Euthanized: A Revealing Study Sheds Light
Involving 59 dogs diagnosed with UC, this retrospective study scrutinized the clinical signs and circumstances surrounding euthanasia after treatments like radiation therapy and chemotherapy. The results were telling: the median survival time for these canine patients was just under a year. Astonishingly, 85% of these dogs were euthanized due to complications directly related to their cancer, with a staggering 62% suffering from local tumor progression leading to complete or partial urinary obstruction.
Zoetis' Shocking Earnings Miss Rocks Investors: What's Next for This Animal Health Giant?
In a surprising turn of events, Zoetis, a leader in the animal health industry, reported quarterly earnings of $1.24 per share, falling short of the Zacks Consensus Estimate of $1.33 per share. This outcome not only startled investors but also marked a significant shift from the company's performance a year ago, which boasted earnings of $1.15 per share, adjusted for non-recurring items. This recent report unveils an earnings surprise of -6.77%, a stark contrast to the previous quarter's surprise of 0.74%, where the company had exceeded earnings expectations.
Zoetis Faces Profit Woes Amid Economic Squeeze
In a stunning turn of events, pet products giant Zoetis (ZTS.N) has just unveiled a profit forecast that falls short of Wall Street's expectations, leaving investors and pet owners alike in a state of disbelief. This Tuesday, the company disclosed a disappointing quarterly performance, with profits taking a hit due to dwindling demand from inflation-stricken pet owners tightening their belts.
Revolutionary Cancer Treatment for Cats Leaves Vets Astonished
In the realm of veterinary medicine, a groundbreaking approach has emerged, offering new hope in the fight against one of the most daunting adversaries: feline cancer. Specifically, basal cell tumors, including the common basal cell carcinomas and the rarer basosquamous carcinomas found on or near the nasal planum in cats, have met their match with electrochemotherapy (ECT), including a novel method known as calcium electroporation. This cutting-edge treatment has been successfully deployed in managing these malignancies in three cats, marking a significant breakthrough in veterinary oncology.